Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Revenue:        
Product revenues $ 0 $ 0 $ 0 $ 0
License revenues 0 0 0 0
Total revenue 0 0 0 0
Cost of product revenue 0 0 0 0
Gross profit 0 0 0 0
Operating Expenses:        
Research and development 241,000 250,000 385,000 475,000
Selling, general and administrative expenses 1,044,000 1,871,000 2,438,000 5,547,000
Total operating expenses 1,285,000 2,121,000 2,823,000 6,022,000
Loss from Operations (1,285,000) (2,121,000) (2,823,000) (6,022,000)
Other income (expense)        
Change in value of warrant and derivative liabilities (367,000) 5,263,000 2,376,000 36,759,000
Interest expense (1,178,000) (1,599,000) (4,698,000) (3,245,000)
Total other income (expense) (1,545,000) 3,664,000 (2,322,000) 33,514,000
Income (loss) before minority interest and provision for income taxes (2,830,000) 1,543,000 (5,145,000) 27,492,000
Plus: net (income) loss attributable to the noncontrolling interest 0 0 0 0
Income before provision for income taxes (2,830,000) 1,543,000 (5,145,000) 27,492,000
Provision for income taxes 0 0 0 0
Net income (loss) $ (2,830,000) $ 1,543,000 $ (5,145,000) $ 27,492,000
Weighted Average Common Shares Outstanding - Basic 479,053 77,785 335,450 67,918
Weighted Average Common Shares Outstanding - Diluted 479,053 84,690 335,450 67,918
Net income (loss) per share - Basic $ (5.91) $ 19.84 $ (15.34) $ 404.78
Net income (loss) per share - Diluted $ (5.91) $ 18.22 $ (15.34) $ 404.78